Monthly archive
- June 2009 (2)
- July 2009 (2)
- August 2009 (6)
- September 2009 (7)
- October 2009 (1)
- November 2009 (2)
- December 2009 (3)
- March 2010 (1)
Blogroll
Case Studies
An NIH study of treatments for high blood pressure, called the ALLHAT trial, shows some of the strengths and limitations of comparative effectiveness research to improve patient care. More...
For Reporters
For journalists and other media professionals
Blog
Researcher knows common flaws in CER studies, dangers of result's misuse
Submitted by Tony Coelho on Mon, 03/08/2010 - 23:13 | Posted in:A recent article by Jerome Groopman, M.D, provides some valuable, first-hand insight as to what can go wrong when policy makers “give teeth” to comparative effectiveness research (CER) studies by translating results into “best practices.” Groopman’s understanding of the limitations of CER and the complexities of delivery high quality care to each patient, lead him to caution against blunt application of CER in ways that do not give physicians the ability to deviat
New USPSTF guidelines underscore need for patient-centered CER
Submitted by Tony Coelho on Wed, 12/16/2009 - 07:18 | Posted in:A few days ago, I posted about what I saw as one of the key lessons from the controversy over the new U.S. Preventive Services Task Force’s (USPSTF) mammography guidelines, namely, that expert panels can sometimes come to different conclusions based on the same evidence.
PIPC urges inclusion of Senate CER provision in final reform legislation
Submitted by Tony Coelho on Thu, 12/10/2009 - 18:24 | Posted in:Agree or disagree with the recent changes to mammography guidelines by the U.S. Preventive Services Task Force (USPSTF), one thing is clear – two sets of highly qualified experts can come to very different conclusions when looking at the same evidence. This holds big implications for provisions of health care reform like comparative effectiveness research (CER).
PIPC Chairman Coelho sits down with SCAA
Submitted by PIPC Staff on Mon, 12/07/2009 - 21:50 | Posted in:Last week, PIPC Chairman Tony Coelho sat down with the Sudden Cardiac Arrest Association (SCAA) to talk about comparative effectiveness research (CER) and how this research and other aspects of health reform will affect patients.
What did the House do for CER?
Submitted by Tony Coelho on Mon, 11/16/2009 - 21:00 | Posted in:The House of Representatives passed their health reform package - the Affordable Health Care for America Act - last Saturday night by a vote of 220 to 215. With all of the provisions packed into the 2,000-page bill, what's in this historic legislation for comparative effectiveness research (CER)?
Senate's consideration of CER must promote research integrity, patient focus
Submitted by Tony Coelho on Thu, 11/12/2009 - 06:40 | Posted in:As the health reform debate continues to the Senate, it’s important to keep the focus on the patient. This is one of the points highlighted in Politico’s health care issue last week.
Health reform measures must leave decision-making to patients, providers
Submitted by Tony Coelho on Wed, 10/07/2009 - 17:52 | Posted in:Will government-supported comparative effectiveness research (CER) come between doctors and patients in making treatment decisions? The jury, I think, is still out.
We all can agree, as stated in a recent blog post by the Center for American Progress (CAP), that the goal of CER is to "permit patients and their health providers to make better decisions about care based on evidence."
Keeping track of Congress
Submitted by PIPC Staff on Tue, 09/29/2009 - 19:19PIPC will be keeping a close eye on the Senate Finance Committee’s work on health reform legislation today. The Committee is expected to discuss possible revisions to the comparative effectiveness research language already in the proposed legislation. Recently, PIPC issued a statement in support of the language in the Chairman Baucus’s bill.
PIPC remains optimistic
Submitted by PIPC Staff on Mon, 09/28/2009 - 18:22PIPC remains optimistic that patient-centered comparative effectiveness research (CER) will be included in health reform legislation, despite its disappointment that the House Energy and Commerce Committee did not act on the bi-partisan patient-centered CER amendment during their work last week.
Congress is back at it
Submitted by admin on Tue, 09/22/2009 - 22:10Tomorrow PIPC Chairman Tony Coelho will participate in a panel discussion on comparative effectiveness research (CER) here in Washington, DC. With Congress back in session and healthcare reform taking center stage, PIPC is continuing to engage Members of Congress about the importance of patient-centered CER.
